J&J Is In Talks to Sell Its Hips-and-Knees Business to Apollo for $20 Billion
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 trends tracked about this subject — the full history, oldest to newest below.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Apollo is reportedly in talks to acquire Johnson & Johnson's hips-and-knees orthopedics business in a potential twenty billion dollar deal.
Johnson & Johnson proposes a $5.5 billion settlement to resolve United States talcum powder litigation.
Johnson & Johnson proposes a $5.5 billion settlement to potentially resolve marathon talc litigation.
Johnson & Johnson proposes a multi-billion dollar payout to resolve ongoing legal battles.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve a decade-long legal battle over cancer claims linked to its baby powder.
Johnson & Johnson shares dip despite a Q2 earnings beat, revenue growth, and an increased full-year guidance raise announced by the CFO.
Johnson & Johnson CEO Joaquin Duato identifies the development of cures for certain types of cancer as a realistic objective for the coming decade.
Johnson & Johnson is directing $55 billion into US operations, linking the strategy to tax policy.